Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Spilling (London, United Kingdom), M. Dhillon (London, United Kingdom), D. Burrage (London, United Kingdom), S. Ruickbie (London, United Kingdom), E. Baker (London, United Kingdom), T. Barrick (London, United Kingdom), P. Jones (London, United Kingdom). Respiratory, cardiovascular and systemic factors associated with brain damage in Chronic Obstructive Pulmonary Disease (COPD) and/or coronary artery disease (CAD). 2220

Member's Comments

No comment yet.

Related content which might interest you: Clinical factors linked with coronary artery disease in chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Chronic obstructive pulmonary disease (COPD) exacerbations and carotid artery plaques: The Rotterdam study Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts Year: 2013 Assessment of cardiovascular comorbidity Source: Eur Respir Mon 2013; 59: 28-49 Year: 2013 Systemic vascular function in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013 Subclinical atherosclerosis, airflow obstruction and emphysema: the MESA Lung Study Source: Eur Respir J 2012; 39: 846-854 Year: 2012 Systemic inflammation and cardiovascular disease in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Chronic obstructive pulmonary disease (COPD) and alterations of hemogram Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Metabolic paralysis in systemic immune cells of Chronic Obstructive Pulmonary Disease (COPD) subjects. Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 The relationship between the severity of obstructive sleep apnea syndrome and severity of chronic obstructive pulmonary disease (COPD) associated with coronary artery disease (CAD) Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Evidence of renal and pulmonary endothelial dysfunction in chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 The metabolic syndrome in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Cardiovascular risk factors in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 624s Year: 2006 Prevalence of chronic obstructive pulmonary disease (COPD) among smokers with stable coronary artery disease (CAD) Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Frequency of depression in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Local and systemic inflammation in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 Venous thromboembolic disease (VTD) associated with inflammatory bowel disease (IBD): RIETE´s experience Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Pulmonary hypertension correction in patients with chronic obstructive pulmonary disease and essential hypertension Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Chronic thromboembolic pulmonary hypertension (CTEPH) Source: Respipedia Article Year: 2018 Mortality associated with the type of heart failure in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD Year: 2016 Pulmonary artery dissection (PAD) in a patient with diffuse interstitial lung disease and chronic thromboembolic pulmonary hypertension (CTEPH) Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016